Skip to main content
Top

Diabetology International

Issue 4/2020

Content (16 Articles)

Report of the Committee

The work style and living condition survey of diabetologists and the expectations for the Japan Diabetes Society: results of questionnaires about the current state and the future prospect of their carrier in 2017

Keiko Naruse, Atsuko Abiko, Hitomi Nakayama, Nobue Tanaka, Kaori Ikeda, Hitomi Imachi, Emi Usigome, Yutaka Umayahara, Setsu Ota, Yukiko Okada, Noriko Kodani, Noriko Takahashi, Ai Terai, Akinobu Nakamura, Rumi Fujikawa, Junnosuke Miura, Emiko Morita, Miyuki Yanagimachi, Kojiro Ueki

Ketoacidosis Introduction to Mini-Reviews

Twenty years since the discovery of fulminant type 1 diabetes

Akira Shimada, Hiroshi Ikegami

Type 1 Diabetes Mini-Review

Genetics of fulminant type 1 diabetes

Yumiko Kawabata, Hiroshi Ikegami

Pancreatitis Mini-Review

Unique pathological changes in the pancreas of fulminant type 1 diabetes

Tetsuro Kobayashi, Shoichiro Tanaka, Kaoru Aida

Review Article

Patient decision aids in clinical practice for people with diabetes: a scoping review

Jodie Cornelius, Frances Doran, Elaine Jefford, Nasim Salehi

Type 2 Diabetes Original Article

Impact of body mass index and age on the relative accuracy of self-reported energy intakes among Japanese patients with type 2 diabetes

Yuki Tanaka, Tomoko Nakagami, Junko Oya, Chieri Ukita-Shibasaki, Yuuka Takehana, Satoshi Sasaki, Tetsuya Babazono

Obesity Original Article

Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes

Saori Maruo, Koka Motoyama, Tomoe Hirota, Yoshinori Kakutani, Yuko Yamazaki, Tomoaki Morioka, Katsuhito Mori, Shinya Fukumoto, Atsushi Shioi, Tetsuo Shoji, Masaaki Inaba, Masanori Emoto

Diabetes Original Article

Effect of a 6-week strength-training program on neuromuscular efficiency in type 2 diabetes mellitus patients

Samira Shahrjerdi, Farid Bahrpeyma, Hans H. C. M. Savelberg, Mohammad Reza Mohajeri-Tehrani

Insulins Original Article

Effect of postprandial moderate-intensity walking for 15-min on glucose homeostasis in type 2 diabetes mellitus patients

Yuji Iida, Soichi Takeishi, Nobutoshi Fushimi, Kazuhiko Tanaka, Akihiro Mori, Yuzo Sato

Insulins Case Report

Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

Hitomi Komatsu, Mariko Enomoto, Hisashi Shiraishi, Yasuyo Morita, Daisuke Hashimoto, Shuichi Nakayama, Shogo Funakoshi, Seiki Hirano, Yoshio Terada, Mitsuhiko Miyamura, Shimpei Fujimoto

Febuxostat Correction

Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

Hitomi Komatsu, Mariko Enomoto, Hisashi Shiraishi, Yasuyo Morita, Daisuke Hashimoto, Shuichi Nakayama, Shogo Funakoshi, Seiki Hirano, Yoshio Terada, Mitsuhiko Miyamura, Shimpei Fujimoto

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine